MAT1A deficiency lowers SAM levels and predisposes individuals to MASLD‐associated HCC, while MAT1 promoter hypermethylation has been linked to hyperhomocysteinemia in cirrhosis.104, 105. Here, MAT1A is linked to hyperhomocysteinemia.